ResMed, a San Diego-based maker of products for sleep disorders, announced Monday it will buy the medical software company Brightree for $800 million. Privately held Brightree, based in Atlanta, makes ...

ResMed, which makes medical equipment and home health management software, said it will acquire MatrixCare in a deal valued at $750 million. MatrixCare, which provides acute long-term healthcare ...

ResMed, the medical device maker based in San Diego, has acquired cloud-based software provider Brightree for $800 million. The purchase marks the third acquisition in the space of just eight months ...

Respiratory specialist ResMed ($RMD) announced that it is acquiring software company Brightree for $800 million in a bid to provide administrative solutions like ...

Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management ...

Connected respiratory device maker ResMed signed a definitive agreement to acquire Medifox Dan, a German out-of-hospital software company, from software investor Hg for $1 billion (€950 million).

Cloud-powered medical device company ResMed has agreed to buy German healthcare software firm Medifox Dan for $1 billion. ResMed, based in San Diego, said it will integrate Medifox Dan’s capabilities ...

San Diego-based medical device company ResMed has announced the acquisition of mementor, a consumer software developer that offers a digital solution for insomnia. The financial terms of the ...

ResMed is taking a “smart devices” and “big data” approach to further entrench itself as one of the two leading players in the global sleep apnea market. The strategy is two-fold – accelerating ...

San Diego’s ResMed, best-known for its sleep apnea devices and ventilators, has inked a deal to buy German health care software outfit MediFox Dan in an all-cash deal valued at $1 billion. The ...

The additional revenue that ResMed has picked up in the wake of competitor Philips’ long-lasting ventilator recall appears to be burning a hole in the devicemaker’s pocket. Fresh off a fiscal quarter ...